Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)
Completed
Conditions studied: Liver Diseases
In brief
The purpose of this study is to see how effective the investigators' optimized magnetic resonance spectroscopy (MRS) sequence in quantifying hepatic triglyceride content (HTGC) to enhance MRS as a diagnostic tool in non-alcohol fatty liver disease (NAFLD).
Key facts
- Study ID
- NCT00940537
- Run by
- Washington University School of Medicine
- People needed
- 14
- Starts
- 2009-06-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2018-06-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Obese
You may not qualify if…
- Diabetes
- Pregnant
Where it is running
- Barnes Jewish Hospital — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.